Archive: 15/03/2016

More variability in overnight insulin requirements in T1DM

(HealthDay)—For individuals with type 1 diabetes, overnight insulin requirements are significantly more variable than daytime and total daily insulin requirements during closed-loop insulin delivery, according to a study ...

Mar 15, 2016

0

1

Recommendations issued for myeloma-tied renal impairment

(HealthDay)—Recommendations have been developed for the diagnosis and management of multiple myeloma-related renal impairment; the guidelines were published online March 14 in the Journal of Clinical Oncology.

Mar 15, 2016

0

2

Off-label use of metformin common in U.S. adolescents

(HealthDay)—In U.S. adolescents, off-label use of metformin is common, according to a study published online March 9 in the Journal of Clinical Pharmacy and Therapeutics.

Mar 15, 2016

0

2

PA32540 safe for patients at risk of aspirin-linked upper GI events

(HealthDay)—For subjects at risk of aspirin-associated upper gastrointestinal (UGI) events, long-term PA32540 (enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) appears to be safe, according to a study ...

Mar 15, 2016

0

0

Could too much cellphone time signal anxiety, depression?

(HealthDay)—Some young adults who constantly reach for their smartphones might be anxious or depressed, preliminary research suggests.

Mar 15, 2016

1

90

'Difficult' patients tend to get worse care, studies find

(HealthDay)—What happens to medical care when the patient is a jerk?

Mar 15, 2016

0

9

Don't take short cuts with contact lens care, FDA warns

(HealthDay)—If you use contact lens solution with hydrogen peroxide and don't follow the instructions carefully, you could be putting your eyes at risk, the U.S. Food and Drug Administration warns.

Mar 15, 2016

1

112

FDA advisers back first dissolving heart stent (Update)

Federal health advisers overwhelmingly backed the safety and effectiveness of an experimental medical implant that dissolves into the body after doing its job.

Mar 15, 2016

0

7

Eli Lilly changes outcome goals in Alzheimer's drug study

Eli Lilly said Tuesday that it's changed the outcome goals for a late-stage patient study of its closely watched experimental drug for Alzheimer's disease, solanezumab.

Mar 15, 2016

Researchers find higher risk of mild cognitive impairment after traumatic brain injury

Traumatic brain injury appears to be related to both increased risk and earlier onset of mild cognitive impairment, UT Southwestern Medical Center researchers report.

Mar 15, 2016

0

153

page 2 from 10

«
»